Welcome to Delta Pharma's dedicated website on Disease-Modifying Antirheumatic Drugs (DMARDs), where we proudly showcase our comprehensive portfolio of treatments designed to improve the lives of individuals battling rheumatic diseases. Since our inception, Delta Pharma has been at the forefront of pioneering healthcare solutions, introducing groundbreaking DMARD therapies to meet the needs of patients across Bangladesh. Among our esteemed lineup, Methotrax stands as a testament to our commitment to excellence,

having been the First-Time in Bangladesh brand since its landmark launch in 2004. Our dedication to innovation continued with the introduction of Reumaflex in 2016, followed by Tofacit in 2018 and Baricit in 2020, each representing significant milestones in our journey towards enhancing patient care. As we forge ahead, we remain steadfast in our mission to deliver cutting-edge treatments, exemplified by the last addition of Upacit XR to our esteemed DMARD portfolio. At Delta Pharma, we are committed to highest quality of product at an affordable price.